Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Advanced Drug Delivery Reviews
|
December 4, 2001
Targeted drug conjugates: principles and progress
M C Garnett
Critical Reviews in Therapeutic Drug Carrier Systems
|
March 8, 2000
Gene-delivery systems using cationic polymers
M C Garnett
Occupational Medicine (Oxford, England)
|
July 27, 2006
Nanomedicines and nanotoxicology: some physiological principles
M C Garnett, P Kallinteri
Anti-Cancer Drug Design
|
January 1, 1995
Studies on the mechanism of action of an MTX-HSA-MoAb conjugate
J J Fitzpatrick, M C Garnett
Cancer Research
|
May 1, 1986
An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines
M C Garnett, R W Baldwin
Anti-Cancer Drug Design
|
January 1, 1995
Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers
J J Fitzpatrick, M C Garnett
European Journal of Cell Biology
|
August 1, 1986
Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates
M C Garnett, R W Baldwin
Molecular Pharmacology
|
June 1, 1994
The acidic groups of the neocarzinostatin protein play an important role in its biological activity
F Schönlau, W Köhnlein, M C Garnett
Journal of Immunological Methods
|
July 26, 1989
Mouse IgG2b monoclonal antibody fragmentation. Preparation and purification of Fab, Fc and Fab/c fragments
S Demignot, M C Garnett, R W Baldwin
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|
March 1, 1997
Mechanism of free and conjugated neocarzinostatin activity: studies on chromophore and protein uptake using a transferrin-neocarzinostatin conjugate
F Schönlau, A Maibücher, W Köhnlein, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Advanced Drug Delivery Reviews
|
December 4, 2001
Targeted drug conjugates: principles and progress
M C Garnett
Critical Reviews in Therapeutic Drug Carrier Systems
|
March 8, 2000
Gene-delivery systems using cationic polymers
M C Garnett
Occupational Medicine (Oxford, England)
|
July 27, 2006
Nanomedicines and nanotoxicology: some physiological principles
M C Garnett, P Kallinteri
Anti-Cancer Drug Design
|
January 1, 1995
Studies on the mechanism of action of an MTX-HSA-MoAb conjugate
J J Fitzpatrick, M C Garnett
Cancer Research
|
May 1, 1986
An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines
M C Garnett, R W Baldwin
Anti-Cancer Drug Design
|
January 1, 1995
Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers
J J Fitzpatrick, M C Garnett
European Journal of Cell Biology
|
August 1, 1986
Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates
M C Garnett, R W Baldwin
Molecular Pharmacology
|
June 1, 1994
The acidic groups of the neocarzinostatin protein play an important role in its biological activity
F Schönlau, W Köhnlein, M C Garnett
Journal of Immunological Methods
|
July 26, 1989
Mouse IgG2b monoclonal antibody fragmentation. Preparation and purification of Fab, Fc and Fab/c fragments
S Demignot, M C Garnett, R W Baldwin
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|
March 1, 1997
Mechanism of free and conjugated neocarzinostatin activity: studies on chromophore and protein uptake using a transferrin-neocarzinostatin conjugate
F Schönlau, A Maibücher, W Köhnlein, et al.
Page
of 5